PRICE T ROWE ASSOCIATES INC /MD/
Position in VNDA — Vanda Pharmaceuticals Inc.
CIK 80255
BALTIMORE, MD
Position in VNDA
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$255,938
-$33,038 QoQ
Shares Held
41,820
0.0% QoQ
Ownership
0.069%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#75
of 172 holders
Holding Since
Mar 2020
20 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in VNDA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026PRICE T ROWE ASSOCIATES INC /MD/ holds $17,555,962,932 across 304 Biotechnology names. VNDA ranks #234 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ARGX |
Argenx SE
|
2,678,047 | $2,484,611,664 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,529,709 | $953,834,749 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,728,421 | $858,558,562 | |
| 4 | KYMR |
Kymera Therapeutics, Inc.
|
7,112,980 | $815,645,416 | |
| 5 | RPRX |
Royalty Pharma plc
|
11,193,657 | $627,628,347 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
2,969,853 | $447,655,945 | |
| 7 | MRNA |
Moderna, Inc.
|
5,589,560 | $391,436,886 | |
| 8 | SRRK |
Scholar Rock Holding Corp
|
6,794,837 | $373,716,035 |
All Filings in VNDA
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $255,938 | 41,820 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $288,976 | 41,820 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $311,196 | 35,283 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $145,987 | 29,256 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $126,330 | 26,765 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $122,851 | 26,765 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $106,649 | 22,265 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $88,617 | 18,895 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $96,219 | 17,030 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $65,036 | 15,824 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $56,543 | 13,399 | Shares | Defined | 2024-02-16 | |
| 2023-09-30 | $52,509 | 12,155 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $75,317 | 11,429 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $70,480 | 10,380 | Shares | Defined | 2023-05-15 | |
| 2021-06-30 ALXN | — | 725,032 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 ALXN | — | 792,319 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 ALXN | — | 1,536,173 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 ALXN | — | 3,115,735 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 ALXN | — | 7,439,840 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 ALXN | — | 8,542,685 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||